FL-411

CAS No. 2118944-88-8

FL-411 ( FL411 )

Catalog No. M13371 CAS No. 2118944-88-8

FL-411 is a novel small-molecule inhibitor of BRD4.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 80 In Stock
10MG 132 In Stock
25MG 267 In Stock
50MG 447 In Stock
100MG 745 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FL-411
  • Note
    Research use only, not for human use.
  • Brief Description
    FL-411 is a novel small-molecule inhibitor of BRD4.
  • Description
    FL-411 is a novel small-molecule inhibitor of BRD4, induces ATG5-dependent autophagy-associated cell death (ACD) by blocking BRD4-AMPK interaction and activating AMPK-mTOR-ULK1-modulated autophagic pathway in breast cancer cells; induces ACD pathways involved in HMGB1, VDAC1/2, and eEF2, displays a therapeutic potential on both breast cancer xenograft mouse and zebrafish models.
  • Synonyms
    FL411
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    BRD4
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    2118944-88-8
  • Formula Weight
    341.43
  • Molecular Formula
    C18H19N3O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ( < 1 mg/ml refers to the product slightly soluble or insoluble )
  • SMILES
    CC1=CC(=CC(=C1O)C)C2=NC3=C(C4=C(S3)CN(CC4)C)C(=O)N2
  • Chemical Name
    2-(4-Hydroxy-3,5-dimethylphenyl)-7-methyl-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ouyang L, et al. J Med Chem. 2017 Dec 28;60(24):9990-10012.
molnova catalog
related products
  • BET-BAY 002

    BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.

  • CeMMEC2

    CeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM.

  • BI 894999

    BI 894999 is a novel potent, selective BET inhibitor with IC50 of 5 and 41 nM for BRD4-BD1 and BRD4-BD2 bromodomains, respectively.